High-Tech Stick Can Predict Your Risk of Heart Problems
August 28, 2019 | RMIT UniversityEstimated reading time: 2 minutes
A hand-held device to predict heart failure based on saliva could help millions of potential victims take preventative steps to avoid their fate.
Nano-sensors on the tip of the diagnostic stick measure heart disease biomarkers to accurately predict the risk of heart disease, failure or heart attack, then warn users via a simple app.
RMIT University and the Innovative Manufacturing Cooperative Research Centre (IMCRC) are now researching and developing the device for pilot manufacture, with expectations it will hit market by 2021, in a collaboration led by Melbourne-based start-up, ESN Cleer.
RMIT University nanotechnology and design experts join forces with ESN Cleer and the Innovative Manufacturing CRC to bring the device to market by 2021. Photo: Adam R. Thomas
ESN Cleer CEO Leopoldt de Bruin said the team represented some of the best minds in medical device innovation, design and manufacture.
“We’re really pleased to be able to bring these strands together in addressing such a major global health challenge,” De Bruin said.
“Of the 400 million people who suffer from cardiovascular disease globally, only 16 per cent of cases are due to genetic traits. This underlines how much room there is to improve on screening and prevention, which is where this device could have such an impact.”
Cardiovascular disease currently accounts for nearly one-third of all global disease deaths each year.
Research Co-Director of RMIT University’s Functional Materials and Microsystems Research Group, Professor Sharath Sriram, said this was the first portable heart disease test with such high levels of accuracy.
The sensing technology, developed at RMIT University’s cutting-edge Micro Nano Research Facility, was validated in the lab to measure biomarker concentrations a thousand times more precisely than levels in human body fluids.
“This marks a big step forward in technology for screening,” Sriram said.
“Often, blood tests are only conducted after a heart failure episode. Such reactive testing is too late, leaving people with debilitating illness or leading to deaths.”
“Prevention is always better than cure, which is where this technology comes in, adding accurate prediction to the mix.”
Page 1 of 2
Suggested Items
iNEMI Names Grace O'Malley CTO
05/02/2024 | iNEMIThe Board of Directors of the International Electronics Manufacturing Initiative (iNEMI) has named Grace O'Malley Chief Technical Officer (CTO).
Intel Takes Next Step Toward Building Scalable Silicon-Based Quantum Processors
05/02/2024 | BUSINESS WIRENature published an Intel research paper, “Probing single electrons across 300-mm spin qubit wafers,” demonstrating state-of-the-art uniformity, fidelity and measurement statistics of spin qubits.
ZESTRON Academy Launches 2024 Advanced Packaging & Power Electronics Webinar Series
05/01/2024 | ZESTRONZESTRON, the leading global provider of high-precision cleaning products, services, and training solutions in the electronics manufacturing and semiconductor industries, proudly announces the launch of its highly anticipated webinar series on Advanced Packaging & Power Electronics, a webinar series on the latest innovations, cleaning, and corrosion challenges.
NextFlex Convenes the Hybrid Electronics Community at Binghamton University
05/01/2024 | NextFlexBinghamton University hosted the NextFlex hybrid electronics community on April 18 for a day of expert presentations, breakout sessions on technology and manufacturing topics, and networking.
HQ NextPCB of HQ Electronics Debut on the International Stage for Electronics Manufacture at IPC APEX 2024
05/01/2024 | PRNewswireHQ NextPCB of HQ Electronics, a leading Chinese-based multilayer PCB manufacturer and assembly house showcased its industrial prowess on the international stage for the first time at the IPC APEX Expo 2024.